Other Oncology.TV sites:

  • Home
  • Continuing Education
  • Oncology TV Network
  • Ask The Experts
  • Symptom Management
  • Events
  • Links
Login | Register
Oncology TV – Your Peer Network
The Oncology TV Network is a way to learn and interact with your peers. Please submit a question regarding the current video playing (“Ask the Experts”) to find out more about this topic. 

For additional information about this and related topics, please visit our partner sites at MPNUniversity.TV. (www.mpnuniversity.tv) and SCUniversity.TV (www.scuniversity.tv)

Please select a video from the list below.
Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer
The following program was filmed at "Fighting a Smarter War Against Cancer", a Symposium presented by The Ruesch Center for the Cure of Gastrointestinal Cancers. Presented by Michael Pishvaian, MD, PhD, Phase I Program Director, Co-Director of the Ruesch Cener Pancreatic Cancer Program, Assistant Professor, Lombardi Comprehensive Cancer Center, Georgetown University.
  • Slide deck: Precision Medicine: The Potential for Identifying Personalized Therapies for Patients with Gastro-Esophageal Cancer
Ask the Experts
Use the space below to submit your questions to the Oncology.TV Experts. (Login required.)
Question:

 
Email Address:

 
progress Please wait....Submitting your Question!
Related Questions
No related Ask The Experts Q&A available.
Recent Video
| 
Most Popular
Specialties :                    Search :
MPN Highlights - ASH 2017
MPN Highlights - ASH 2017 Views - 76
Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk PV or High-Risk Essential Thrombocythemia
Single-Arm Salvage Therapy with Pegylated Interferon Alfa-2a for Patients with High-Risk PV or High-Risk Essential Thrombocythemia Views - 44
The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis among Older Patients with Polycythemia Vera
The Impact of Phlebotomy and Hydroxyurea on Survival and Risk of Thrombosis among Older Patients with Polycythemia Vera Views - 40
Validation of the Myelofibrosis Secondary to PV and ET – Prognostic Model in Patients with Post-PV and Post-Essential Thrombocythemia
Validation of the Myelofibrosis Secondary to PV and ET – Prognostic Model in Patients with Post-PV and Post-Essential Thrombocythemia Views - 26
Characteristics of Patients with Chronic Phase Myelofibrosis and Elevated Blasts (5-9%), and the Effect of JAK2 Inhibitor Ruxolitinib
Characteristics of Patients with Chronic Phase Myelofibrosis and Elevated Blasts (5-9%), and the Effect of JAK2 Inhibitor Ruxolitinib Views - 37
Myelofibrosis (MF) Leukemic Transformation (LT) in the Era of Ruxolitinib and Genomics: Characteristics and Outcomes
Myelofibrosis (MF) Leukemic Transformation (LT) in the Era of Ruxolitinib and Genomics: Characteristics and Outcomes Views - 54
Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea
Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea Views - 48
Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated With Hydroxyurea in the United States: an Analysis Fro
Examining the Treatment Patterns and Blood Counts Among Patients with Polycythemia Vera Treated With Hydroxyurea in the United States: an Analysis Fro Views - 35
Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis From the REVEAL Study
Patient-Reported Symptom Burden and Peripheral Blood Counts Among Patients with Polycythemia Vera: An Analysis From the REVEAL Study Views - 40
Sotatercept (ACE-011) Alone and with Ruxolitinib in Patients with MPN-associated Myelofibrosis (MF) and Anemia with Ruxolitinib or Hydroxyurea
Sotatercept (ACE-011) Alone and with Ruxolitinib in Patients with MPN-associated Myelofibrosis (MF) and Anemia with Ruxolitinib or Hydroxyurea Views - 49
Full-Dose Betrixaban Reduces Venous Thromboembolism-Related Mortality: An APEX Trial Substudy
Full-Dose Betrixaban Reduces Venous Thromboembolism-Related Mortality: An APEX Trial Substudy Views - 38
New Oral Anticoagulants for Cancer-Associated Venous Thromboembolism: A Meta-Analysis
New Oral Anticoagulants for Cancer-Associated Venous Thromboembolism: A Meta-Analysis Views - 15
Biology and Targeting of Eosinophilic MPNs
Biology and Targeting of Eosinophilic MPNs Views - 7
Perspectives and Future Directions in ET and PV
Perspectives and Future Directions in ET and PV Views - 6
The Challenge Of Tackling MDS/MPN
The Challenge Of Tackling MDS/MPN Views - 5
Novel Agents and Combination Strategies in MF
Novel Agents and Combination Strategies in MF Views - 6
Animal Models of MPN - What Do They Teach Us?
Animal Models of MPN - What Do They Teach Us? Views - 6
What Does This Patient Have: ET, PV or Masked PV?
What Does This Patient Have: ET, PV or Masked PV? Views - 5
Identifying Signs of Sepsis: Challenges in Implementing Sepsis Core Measure
Identifying Signs of Sepsis: Challenges in Implementing Sepsis Core Measure Views - 205
Pharmacology Update in Oncology: 2017
Pharmacology Update in Oncology: 2017 Views - 282
Low Health Literacy and Cancer Survivorship: We
Low Health Literacy and Cancer Survivorship: We've Got Some Explaining to Do Views - 107
The Terror of Cancer: The View from the Other Side of the Hospital Gown
The Terror of Cancer: The View from the Other Side of the Hospital Gown Views - 175
Care Coordination: Managing the Needs of the Complex, Chronically Ill Patient
Care Coordination: Managing the Needs of the Complex, Chronically Ill Patient Views - 181
LGBTQ Savvy: Law, Policy, and Diversity
LGBTQ Savvy: Law, Policy, and Diversity Views - 85
Medical Marijuana: It
Medical Marijuana: It's Not How High, But How Far We Can Go Views - 147
Impact of Patient Reported Symptoms on Physical Function and Quality of Life in Adults with Acute Leukemia
Impact of Patient Reported Symptoms on Physical Function and Quality of Life in Adults with Acute Leukemia Views - 73
Neuropathic Pain in Cancer Patients: The use of Multimodal Therapy to Increase Success
Neuropathic Pain in Cancer Patients: The use of Multimodal Therapy to Increase Success Views - 208
Sickle Cell Disease Pain Management
Sickle Cell Disease Pain Management Views - 110
Immunotherapy - Psychosocial & Educational Considerations and Resources
Immunotherapy - Psychosocial & Educational Considerations and Resources Views - 289
Immunotherapy - Oncolytic Viral Therapies - Overview and Clinical Applications
Immunotherapy - Oncolytic Viral Therapies - Overview and Clinical Applications Views - 107
Pages:
1 2 3 4 5 6 7 8 9 10 11
... Next
ABOUT ONCOLOGY.TV

Oncology.TV offers physicians, nurses, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), and other news and information on a variety of tumor types.

SOCIAL MEDIA
OTHER ONCOLOGY.TV SITES 

 
 

PARTNER SITES
 
Privacy Statement  |   Terms Of Use  |  Contact Oncology.TV  |   Copyright 2018 by Oncology.TV